Subtype
Urinary Tract Non-Urothelial Carcinoma
CI-CAN-00008587Explore in graph →
7 active trials1 evidence items
- NCIt
- C212819
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00008587Explore in graph →
Clinical trials
16 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (5)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03912818 | Durvalumab and Standard Chemotherapy Before Surgery in Treating Patients With Variant Histology Bladder Cancer | terminated | Phase 2 | 7 | Stanford UniversityOTHER | 1 | Sep 11, 2023 | clinicaltrials |
| NCT01954173 | Adjuvant Radiation for High Risk Bladder Cancer | terminated | N/A | 19 | Emory UniversityOTHER | 1 | Mar 2, 2022 | clinicaltrials |
| NCT01611662 |
| Gemcitabine Hydrochloride and Cisplatin Before Surgery in Treating Patients With Muscle Invasive Bladder Cancer |
| terminated |
| Phase 2 |
| 32 |
| Fox Chase Cancer CenterOTHER |
| 1 |
| Jul 29, 2019 |
| clinicaltrials |
| NCT00072137 | Neoadjuvant Intravesical Vaccine Therapy in Treating Patients With Bladder Carcinoma Who Are Undergoing Cystectomy | terminated | Phase 1 | 21 | National Cancer Institute (NCI)NIH | 1 | Dec 23, 2014 | clinicaltrials |
| NCT00112905 | Sorafenib in Treating Patients With Regional or Metastatic Cancer of the Urothelium | terminated | Phase 2 | 27 | National Cancer Institute (NCI)NIH | 1 | May 30, 2014 | clinicaltrials |
Data updated 22 days agoSource updated Sep 11, 2023source: clinicaltrials